Family Medicine · Scottsdale, AZ
NPI
1679570832
Since 2005
Specialty
Family Medicine
Code 207Q00000X
Group practices
0
Medicare group memberships
Hospitals
1
Hospital affiliations
10210 N 92nd St, Suite 305
Scottsdale, AZ, 85258
Phone (480) 551-6979
Medicare paid, 2024
$106K
2,940 services
Medicare patients, 2024
228
Average age 77
Drug cost, 2024
$505K
4,374 prescriptions
Company payments, 2025
$439
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark M Medeiros was code J0897 (injection, denosumab, 1 mg), 1,440 times for 13 patients. In total Mark M Medeiros billed 2,940 services in 36 codes, and Medicare paid $106K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-06-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 1,440 | 13 | $20.48 | $29K |
| 99213 Office E&M - Established | Office | 357 | 171 | $58.40 | $21K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 343 | 162 | $11.37 | $3,900 |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 144 | 144 | $125.07 | $18K |
| 99214 Office E&M - Established | Office | 114 | 80 | $83.66 | $9,537 |
| G0008 Administration of influenza virus vaccine | Office | 100 | 99 | $31.38 | $3,138 |
| 90653 Vaccine Product | Office | 99 | 98 | $81.82 | $8,100 |
| 36415 Venipuncture Blood Collection | Office | 93 | 78 | $8.65 | $804 |
| 96372 Injection Administration | Office | 51 | 18 | $10.03 | $511 |
| 81002 Clinical Chemistry | Office | 34 | 30 | $3.41 | $116 |
| 99212 Office E&M - Established | Office | 33 | 29 | $33.59 | $1,109 |
| 99215 Office E&M - Established | Office | 27 | 25 | $116.18 | $3,137 |
| 99204 Office E&M - New | Office | 15 | 15 | $111.37 | $1,671 |
| 99203 Office E&M - New | Office | 12 | 12 | $51.28 | $615 |
By year: 2022 $77K for 1,956 services; 2023 $91K for 2,317 services; 2024 $106K for 2,940 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 93 | 78 | $8.65 | $804 |
| 81002 Clinical Chemistry | 34 | 30 | $3.41 | $116 |
Medicare prescription drug claims, 2024
In 2024, the drug Mark M Medeiros prescribed most often to Medicare patients was Rosuvastatin Calcium, with 249 prescriptions and refills. In total Mark M Medeiros wrote 4,374 Medicare prescriptions that cost $505K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 249 | 686 | 71 | $4,435 |
| Amlodipine Besylate Generic | 220 | 563 | 53 | $1,688 |
| Atorvastatin Calcium Generic | 201 | 588 | 60 | $1,446 |
| Levothyroxine Sodium Generic | 191 | 522 | 49 | $2,208 |
| Losartan Potassium Generic | 112 | 298 | 31 | $1,119 |
| Tamsulosin Hcl Generic | 90 | 265 | 25 | $1,581 |
| Lisinopril Generic | 89 | 235 | 27 | $852 |
| Ezetimibe Generic | 88 | 266 | 27 | $2,133 |
| Pantoprazole Sodium Generic | 83 | 204 | 26 | $1,609 |
| Metformin Hcl Er Metformin Hcl | 69 | 200 | 21 | $774 |
| Gabapentin Generic | 65 | 148 | 23 | $981 |
| Metoprolol Succinate Generic | 60 | 175 | 19 | $566 |
| Ramipril Generic | 54 | 149 | 14 | $354 |
| Duloxetine Hcl Generic | 54 | 120 | 12 | $1,277 |
| Montelukast Sodium Generic | 50 | 129 | 12 | $717 |
Brand drugs: 538 claims; generic drugs: 3,822 claims; opioid claims: 86.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark M Medeiros $439 ($439 in general payments such as food, travel and fees) from 10 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $145.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 7 | $145 |
| Medtronic, Inc. MDT | 2 | $63.48 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $51.76 |
| Cleerly, Inc. | 1 | $50.48 |
| Lilly USA, LLC LLY | 2 | $37.4 |
| Novo Nordisk Inc NVO | 1 | $24.61 |
| Abbott Laboratories ABT | 1 | $20.15 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18.74 |
| Globus Medical, Inc. GMED | 1 | $14.15 |
| Exact Sciences Corporation EXAS | 1 | $13.57 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.